SPECT myocardial perfusion imaging as an endpoint

Journal of Nuclear Cardiology

Volumn 19, Issue 5, 2012, Pages 891-894

  Sherwood, Melody ^a   Hage, Fadi G ^b   Heo, Jack ^a   Shaw, Leslee J ^c   Cerqueira, Manuel D ^d   Iskandrian, Ami E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL (TOPIC); EXERCISE TEST; GLOBAL ASSESSMENT; HEMODYNAMIC PARAMETERS; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING SOFTWARE; MYOCARDIAL PERFUSION IMAGING; PARAMETERS; PATIENT CARE; PATIENT SELECTION; POLAR MAP; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGIONAL ASSESSMENT; REPRODUCIBILITY; RESTING PERFUSION; REVIEW; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUMMED DIFFERENCE SCORE; SUMMED REST SCORE; SUMMED STRESS SCORE;

EXERCISE TEST; HUMANS; MYOCARDIAL PERFUSION IMAGING; PATIENT SELECTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84868194904     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9583-0     Document Type: Review

References (16)

1. Iskandrian AE, Garcia EV, editors. Atlas of nuclear cardiology: Imaging companion to Braunwald's heart disease. Philadelphia, PA: Elsevier; 2012.
2. Iskandrian AE, Garcia EV, editors. Nuclear cardiac imaging: Principles and applications. 4th ed. Oxford: Oxford University Press; 2008.
3. https://www.ischemiatrial.org. Accessed 31 May 2012
4. Perin EC, Willerson JT, Pepine CJ, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure. The FOCUS-CCTRN Trial. JAMA 2012; 317:1702-6.
5. Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. J Nuc Cardiol 2012. doi:10.1007/ s12350-012-9548-3
6. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.
7. Slomka P, Xu Y, Berman DS, Germano G. Quantitative analysis of perfusion studies: Strengths and pitfalls. J Nucl Cardiol 2012; 19:338-46.
8. Germano G, Kavanagh PB, Slomka PJ, Berman DS. Tracking a therapeutic response: How reliable are serial measurements of LV perfusion and function? J Nucl Cardiol 2012;19:360-3.
9. Iskandrian AE, Garcia EV, Faber T. Analysis of serial images: A challenge and an opportunity. J Nucl Cardiol 2008;15:23-6.
10. Faber TL, Modersitzki J, Folks RD, et al. Detecting changes in serial myocardial perfusion SPECT: A simulation study. J Nucl Cardiol 2005;12:302-10.
11. Xu Y, Hayes S, Ali I, et al. Automatic and visual reproducibility of perfusion and function measures for myocardial perfusion SPECT. J Nucl Cardiol 2010;17:1050-7.
12. Ficaro EP, Lee BC, Kritzman JN, et al. 4DM: The Michigan method for quantitative nuclear cardiology. J Nucl Cardiol 2007; 14:455-65.
13. Germano G, Kavanagh PB, Slomka PJ, et al. Quantitation in gated perfusion SPECT imaging: The Cedars-Sinai approach. J Nucl Cardiol 2007;14:433-54.
14. Liu YH. Quantification of nuclear cardiac images: The Yale approach. J Nucl Cardiol 2007;14:483-91.
15. Garcia EV, Faber TL, Cooke CD, et al. The increasing role of quantification in clinical nuclear cardiology: The Emory approach. J Nucl Cardiol 2007;14:420-32.
16. Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: A quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2009;2:959-68.